Trials / Conditions / Malignant Paraganglioma

Malignant Paraganglioma

4 registered clinical trials studyying Malignant Paraganglioma.

Status	Trial	Sponsor	Phase
Completed	The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma NCT04860700	Peking Union Medical College Hospital	Phase 2
Completed	Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be R NCT03008369	Mayo Clinic	Phase 2
Completed	Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metasta NCT02592356	M.D. Anderson Cancer Center	N/A
Completed	Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258	University of Southern California	Phase 1